NEUROD1 and stroke disorder: In summary, this novel gene therapy mediated by NeuroD1 can produce new effective neurons in patients within 10–30 days of stroke, which may provide stroke patients with a wider treatment time window, thus solving an urgent clinical problem (Ge et al., 2020).